Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Pipeline UpdateArcus Biosciences, a clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for cancer patients, has announce
* This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Arcus...
Division 1 swimming: Acton-Boxboro girls extend legacy
BOSTON – When the seniors on the Acton-Boxboro girls swimming and diving team were freshmen in 2021, the outgoing class they learned from passed the...
Callahan: The Patriots’ win at Chicago showed us something new
CHICAGO — By now, we know that Drake Maye dazzles. That Christian Gonzalez can lock down a No. 1 receiver like he’s a walking home...
Celebrating veterans: Boston area gears up to honor those who served
The Greater Boston area is ready to honor those who’ve served the country this Veterans Day, from free coffee and doughnuts to new citywide tax...
Four Personal Finance Trends to Watch
By Rodd Mann We present four key categories that may impact many of you, along with the decisions you must make in the years ahead....
Sezzle (NASDAQ:SEZL) Issues FY 2024 Earnings Guidance
Sezzle (NASDAQ:SEZL – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 9.800-9.800 for the...